GlassScriptPhysician profile
Steven J Rivers
NPI 1477589950
$10,363.59
in general payments reported to CMS, 2019-2025
53 companies · $1,319 in 2025
The $1,319 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,734 · 2020: $1,644 · 2021: $1,620 · 2022: $1,367 · 2023: $1,334 · 2024: $1,345 · 2025: $1,319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,998.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,122.90 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $913.91 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $902.54 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Amarin Pharma, INC. | $684.06 | 2019-2023 | |
| Amgen INC. | $568.72 | 2019-2025 | Evenity, Prolia, Krystexxa |
| Abbvie INC. | $509.85 | 2019-2025 | Ubrelvy, Viberzi, Linzess |
| Merck Sharp & Dohme LLC | $437.68 | 2019-2025 | Verquvo, Steglatro, Belsomra |
| Lilly USA, LLC | $400.39 | 2019-2025 | Jardiance, Mounjaro, Emgality |
| Sumitomo Pharma America, INC. | $378.38 | 2023-2025 | Gemtesa |
| Novartis Pharmaceuticals Corporation | $347.58 | 2019-2025 | |
| Pfizer INC. | $342.39 | 2019-2025 | |
| Mylan Specialty L.P. | $303.71 | 2019-2024 | Yupelri |
| Kowa Pharmaceuticals America, INC. | $259.28 | 2019-2023 | Seglentis, Livalo |
| Janssen Pharmaceuticals, INC | $237.65 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $232.38 | 2019-2022 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $213.49 | 2019-2024 | Jardiance |
| Renalytix Ai, INC. | $185.87 | 2024-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Bayer Healthcare Pharmaceuticals INC. | $173.76 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $146.01 | 2019-2025 | Xifaxan, Trulance |
| Exact Sciences Corporation | $140.39 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Otsuka America Pharmaceutical, INC. | $131.88 | 2024-2025 | Rexulti |
| Tosoh Bioscience, INC. | $110.00 | 2019 | |
| Antares Pharma, INC. | $101.89 | 2019-2022 | |
| Daiichi Sankyo INC. | $99.90 | 2022 | |
| Boston Scientific Corporation | $96.06 | 2024-2025 | General - Pain Management, Watchman Flx |
| Esperion Therapeutics, INC. | $92.87 | 2021-2023 | Nexletol |
| Idorsia Pharmaceuticals US INC | $92.77 | 2022-2023 | Quviviq |
| Teva Pharmaceuticals USA, INC. | $92.46 | 2022-2023 | Ajovy, Austedo |
| Philips North America LLC | $91.60 | 2020-2025 | Ecc Solutions, (Ck4) Mcot, Extended Holter |
| Nestle Healthcare Nutrition INC. | $84.02 | 2021-2023 | |
| Radius Health, INC. | $83.07 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $76.95 | 2019-2023 | Eliquis |
| Allergan, INC. | $65.87 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $64.59 | 2019-2021 | |
| Eisai INC. | $54.64 | 2021-2022 | |
| Sanofi Pasteur INC. | $54.53 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $52.09 | 2022 | |
| Astellas Pharma US INC | $51.75 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $43.91 | 2021 | |
| Abbott Laboratories | $42.36 | 2022-2023 | Freestyle Libre 2 |
| Azurity Pharmaceuticals, INC. | $35.65 | 2025 | Horizant, Edarbi |
| Viatris Specialty LLC | $29.85 | 2025 | Yupelri |
| Dexcom, INC. | $29.35 | 2024 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $24.83 | 2025 | Voquezna |
| Lifescan, INC. | $21.34 | 2023 | |
| Bioventus LLC | $20.40 | 2022 | |
| Ibsa Pharma INC. | $19.91 | 2020 | |
| Aimmune Therapeutics, INC. | $19.77 | 2024 | |
| Axsome Therapeutics, INC. | $18.56 | 2025 | Auvelity |
| Shire North American Group INC | $18.27 | 2019 | |
| Medtronic Vascular, INC. | $15.75 | 2019 | |
| Biotronik INC. | $13.65 | 2023 | Biomonitor |
| Biosense Webster, INC. | $12.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Rivers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.